Vivani Medical
VANI | NASDAQ
$1.02
+$0.01 (+0.99%)
At close: Nov 16, 2026, 4:00 PM ET
$1.00
-$0.02 (-2.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
Vivani Medical Company Profile
Company profile explainedCompany Profile
Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases. Its pipeline includes NPM-139 for chronic weight management in patients who are obese or overweight; NPM-133 a semaglutide implant for the treatment of patients with type 2 diabetes; NPM-115, an exenatide implant candidate for chronic weight management in patients who are obese or overweight; and OKV-119, an exenatide implant for the treatment of obesity and diabetes in companion animals, including cats and dogs. The company is headquartered in Alameda, California.
Key Executives
| Name | Position |
|---|---|
| Adam Mendelsohn | Co-Founder, Chief Executive Officer & Director |
| Anthony Edward Baldor | Chief Financial Officer |
| Donald Dwyer | Chief Business Officer & Corporate Secretary |
| Lisa E. Porter | Chief Medical Officer |
| Truc Le | Chief Operations Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 30, 2026 | 8-K | Current Report |
| Oct 29, 2026 | 8-K | Current Report |
| Oct 19, 2026 | 4 | Filing |
| Sep 25, 2026 | 424B5 | Filing |
| Sep 16, 2026 | 8-K | Current Report |
| Aug 17, 2026 | 8-K | Current Report |
| Aug 13, 2026 | 8-K | Current Report |
| Aug 13, 2026 | 10-Q | Quarterly Report |
| Aug 06, 2026 | 8-K | Current Report |
| Jul 30, 2026 | 4 | Filing |
Vivani Medical
| Country | United States |
| IPO Date | Nov 19, 2014 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 42 |
| CEO | Adam Mendelsohn |
Contact Details
1350 S. Loop Road Alameda,
California 94502 United States
Stock Details
| Ticker Symbol | VANI |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001266806 |
| CUSIP Number | 92854B109 |
| ISIN Number | US92854B1098 |
| SIC Code | 3845 |
Add to Watchlist
Select watchlists to add or remove VANI